Summary Gambacciani et al. [1] performed a prospective pilot study to evaluate the effects of associating a neodymium:yt-trium–aluminum–garnet (Nd:YAG) laser with a vaginal erbium laser (VEL), as a non-ablative photothermal therapy for superficial dyspareunia in postmenopausal women (PMW) suffering of the genitourinary syndrome of menopause (GSM). Two groups of sexually active PMW reporting superficial dyspareunia… Read More
Which severe symptoms of menopause are risk factors for women's cognition
Summary A recent cross-sectional study was conducted by an Indian university on whether women's cognitive abilities are sensitive to the severity of menopausal symptoms [1]. The study involved 404 rural women aged 40 to 65 years who completed the Green Climacteric Scale to assess the severity of menopausal symptoms and the Hindi Mini-Mental State Examination… Read More
Microablative fractional radiofrequency as a therapeutic option for vulvar lichen sclerosus: a pilot study
Summary Vulvar lichen sclerous (VLS) is an important concern after the menopause and is caused by chronic vulvar inflammation associated to low levels of estrogen. Pruritus and burning sensation in the affected areas of depigmentation are usually the most frequently reported symptoms, causing dyspareunia and sexual dysfunction. Topic corticoid treatment, although effective, is often discontinued… Read More
Hormonal and menopausal symptom correlates of cognition during the perimenopause
Summary Weber et al. [1] reported on a longitudinal study that was conducted over three waves from 2005 through 2016. For the duration of the study, all 85 subjects were in their perimenopause stage (STRAW+10 stage -2 to stage +1a) and evaluated over 400 bi-annual visits. A comprehensive neuropsychological battery was administered, menopausal symptoms evaluated and 17β-estradiol… Read More
Endometriosis del tracto urinario diagnosticada en una mujer perimenopáusica: Reporte de un caso
El Caso Una mujer perimenopáusica de 47 años con sangrado uterino anormal y dispareunia ingresó en nuestro hospital. El examen rectovaginal de la paciente reveló sensibilidad de la bolsa de Douglas. Su ecografía mostró un endometrioma izquierdo y adenomiosis. Su historial médico previo reveló que su riñón izquierdo estaba en el borde de la entrada… Read More
Regímenes de terapia hormonal y cáncer de endometrio: ¿Importan?
Resumen Los autores del presente estudio [1] estaban interesados en evaluar el riesgo de cáncer de endometrio (CE) en mujeres que usan terapia hormonal menopáusica (THM). Realizaron una búsqueda bibliográfica en las bases de datos de PubMed y Cochrane e identificaron treinta y un estudios entre 2000 y 2020 que reportaban sobre la incidencia y… Read More
Are there differences in symptoms experienced by midlife women with and without the metabolic syndrome?
Summary Midlife women with the metabolic syndrome (MS) are at a higher risk of experiencing a broad array of symptoms. Recently, Min et al. [1] published a scoping review aimed at identifying the prevalence, types, and clustering of symptoms in climacteric women comparing those with or without the MS. The authors performed a three-step search… Read More
Can menopausal hormone therapy improve quality of sleep?
Summary Recently a systematic review and meta-analysis was conducted at West China School of Medical, Sichuan University, China, aimed at investigating whether menopausal hormone therapy can improve sleep quality [1]. The authors included randomized controlled trials (RCTs) from multiple databases, abstracts, and other full-text sources. Fifteen studies were included (n=27,715). The meta-analysis showed that hormone… Read More
Estetrol a promising native estrogen for oral contraception and the relief of menopausal symptoms
Summary The use of hormonal therapy has been associated with an increased risk of venous thromboembolism (VTE) and breast cancer. Recently, Gérard et al. [1] reported in a narrative review the profile of estetrol (E4), an estrogen produced by the human fetal liver, with properties that may provide a better safety profile. Unlike other estrogens,… Read More
Association between parity and bone mineral density in postmenopausal women
Summary Pregnancy has been considered a risk factor for developing osteoporosis. Although there has been much research in the field of bone health, the relationship between parity and bone mineral density (BMD) is still controversial. Recently, Yang et al. [1] reported the results of a cross-sectional study that used data from the National Health and… Read More
